Interviews
Advertisement
Advertisement
Advertisement
Dana Goldman, PhD discusses the results of a Journal of the American Medical Association study analyzing the effects of cost increases in children's asthma medication.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
US Measles Cases Climb, Raising Questions About Preparedness and Prevention
2
FDA Awards National Priority Voucher to Teclistamab Plus Daratumumab in Relapsed/Refractory Multiple Myeloma
3
Soaring off the Patent Cliff: Preparing for the Next Wave of Oncology Biosimilars
4
FDA Approves Depemokimab as Add-On Maintenance Treatment in Severe Asthma
5